...
search icon
hcwb-img

HCW Biologics Inc, Common Stock

HCWB

NMQ

$0.39

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$17.42M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
149.54K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.84
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.21 L
$1.93 H
$0.39

About HCW Biologics Inc, Common Stock

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. The company was incorporated in 2018 and is headquartered in Miramar, Florida. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameHCWBSectorS&P500
1-Week Return-2.5%1.67%0.11%
1-Month Return11.43%3.31%1.23%
3-Month Return-45.04%2.21%2.87%
6-Month Return-9.11%-4.82%8.93%
1-Year Return-65.19%1.22%22.83%
3-Year Return-81.52%15.75%42.13%
5-Year Return-93.81%42.34%83.14%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-4.10M4.10M6.72M2.84M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":60.99,"profit":true},{"date":"2021-12-31","value":60.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.28,"profit":true}]
Cost of Revenue421.82K-543.60K4.14M2.28M[{"date":"2019-12-31","value":10.2,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":13.14,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":55.16,"profit":true}]
Gross Profit(421.82K)4.10M(543.60K)2.59M560.36K[{"date":"2019-12-31","value":-10.29,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-13.26,"profit":false},{"date":"2022-12-31","value":63.09,"profit":true},{"date":"2023-12-31","value":13.67,"profit":true}]
Gross Margin-100.00%(13.26%)38.48%19.72%[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-13.26,"profit":false},{"date":"2022-12-31","value":38.48,"profit":true},{"date":"2023-12-31","value":19.72,"profit":true}]
Operating Expenses7.37M9.92M13.37M17.67M26.28M[{"date":"2019-12-31","value":28.03,"profit":true},{"date":"2020-12-31","value":37.77,"profit":true},{"date":"2021-12-31","value":50.87,"profit":true},{"date":"2022-12-31","value":67.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(7.37M)(5.82M)(13.37M)(15.08M)(25.72M)[{"date":"2019-12-31","value":-736527400,"profit":false},{"date":"2020-12-31","value":-582452500,"profit":false},{"date":"2021-12-31","value":-1336783400,"profit":false},{"date":"2022-12-31","value":-1507877800,"profit":false},{"date":"2023-12-31","value":-2571716000,"profit":false}]
Total Non-Operating Income/Expense144.71K44.65K1.01M51.41K343.94K[{"date":"2019-12-31","value":14.32,"profit":true},{"date":"2020-12-31","value":4.42,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":5.09,"profit":true},{"date":"2023-12-31","value":34.03,"profit":true}]
Pre-Tax Income(7.29M)(5.80M)(12.86M)(14.90M)(24.99M)[{"date":"2019-12-31","value":-729292100,"profit":false},{"date":"2020-12-31","value":-580220100,"profit":false},{"date":"2021-12-31","value":-1286246800,"profit":false},{"date":"2022-12-31","value":-1490070300,"profit":false},{"date":"2023-12-31","value":-2499427700,"profit":false}]
Income Taxes(72.35K)(22.32K)(505.37K)(178.07K)(4.00)[{"date":"2019-12-31","value":-7235300,"profit":false},{"date":"2020-12-31","value":-2232400,"profit":false},{"date":"2021-12-31","value":-50536600,"profit":false},{"date":"2022-12-31","value":-17807500,"profit":false},{"date":"2023-12-31","value":-400,"profit":false}]
Income After Taxes(7.22M)(5.78M)(12.36M)(14.72M)(24.99M)[{"date":"2019-12-31","value":-722056800,"profit":false},{"date":"2020-12-31","value":-577987700,"profit":false},{"date":"2021-12-31","value":-1235710200,"profit":false},{"date":"2022-12-31","value":-1472262800,"profit":false},{"date":"2023-12-31","value":-2499427300,"profit":false}]
Income From Continuous Operations(7.29M)(5.80M)(12.86M)(15.21M)(19.73M)[{"date":"2019-12-31","value":-729292100,"profit":false},{"date":"2020-12-31","value":-580220100,"profit":false},{"date":"2021-12-31","value":-1286246800,"profit":false},{"date":"2022-12-31","value":-1520543800,"profit":false},{"date":"2023-12-31","value":-1973248700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(7.22M)(5.78M)(12.36M)(14.72M)(24.99M)[{"date":"2019-12-31","value":-722056800,"profit":false},{"date":"2020-12-31","value":-577987700,"profit":false},{"date":"2021-12-31","value":-1235710200,"profit":false},{"date":"2022-12-31","value":-1472262800,"profit":false},{"date":"2023-12-31","value":-2499427700,"profit":false}]
EPS (Diluted)(0.56)(1.96)(1.11)(0.42)(0.70)[{"date":"2019-12-31","value":-56.29,"profit":false},{"date":"2020-12-31","value":-196.41,"profit":false},{"date":"2021-12-31","value":-110.7,"profit":false},{"date":"2022-12-31","value":-42,"profit":false},{"date":"2023-12-31","value":-70,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HCWB
Cash Ratio 0.03
Current Ratio 0.07

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HCWB
ROA (LTM) -70.09%
ROE (LTM) -344.32%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HCWB
Debt Ratio Lower is generally better. Negative is bad. 1.38
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.38

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HCWB
Trailing PE NM
Forward PE NM
P/S (TTM) 4.98
P/B 2.80
Price/FCF NM
EV/R 8.35
EV/Ebitda NM

FAQs

What is HCW Biologics Inc share price today?

HCW Biologics Inc (HCWB) share price today is $0.39

Can Indians buy HCW Biologics Inc shares?

Yes, Indians can buy shares of HCW Biologics Inc (HCWB) on Vested. To buy HCW Biologics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HCWB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of HCW Biologics Inc be purchased?

Yes, you can purchase fractional shares of HCW Biologics Inc (HCWB) via the Vested app. You can start investing in HCW Biologics Inc (HCWB) with a minimum investment of $1.

How to invest in HCW Biologics Inc shares from India?

You can invest in shares of HCW Biologics Inc (HCWB) via Vested in three simple steps:

  • Click on Sign Up or Invest in HCWB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in HCW Biologics Inc shares
What is HCW Biologics Inc 52-week high and low stock price?

The 52-week high price of HCW Biologics Inc (HCWB) is $1.93. The 52-week low price of HCW Biologics Inc (HCWB) is $0.21.

What is HCW Biologics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of HCW Biologics Inc (HCWB) is 2.80

What is the Market Cap of HCW Biologics Inc?

The market capitalization of HCW Biologics Inc (HCWB) is $17.42M

What is HCW Biologics Inc’s stock symbol?

The stock symbol (or ticker) of HCW Biologics Inc is HCWB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top